Investor Relations

TriEye company is launching a capital increase campaign hosted by the Norwegian crowdfunding platform Folkeinvest in order to gain strength and speed in our international expansion.

Patent

TriEye has an extensive international patent pending program PCT/EP 2018/073198.

Patent was granted in USA in February 2022 and in Europe in October 2022. Still pending in other countries.